TCAF Holdings — T. Rowe Price Capital Appreciation Equity ETF
All 91 reported holdings of T. Rowe Price Capital Appreciation Equity ETF (TCAF) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Amazon.com, Inc. | 5.83% | $431.30M |
| NVIDIA Corp. | 5.30% | $392.41M |
| Microsoft Corp. | 5.14% | $380.25M |
| Apple, Inc. | 4.70% | $348.10M |
| Alphabet, Inc. Cl A | 4.36% | $322.57M |
| Meta Platforms, Inc.-Class A | 4.18% | $309.08M |
| Broadcom, Inc. | 3.14% | $232.64M |
| Centerpoint Energy, Inc. | 3.03% | $224.39M |
| Advanced Micro Devices | 2.65% | $196.31M |
| Keurig Dr Pepper, Inc. | 2.60% | $192.70M |
| Nisource, Inc. | 2.42% | $179.05M |
| Taiwan Semiconductor-Sp ADR | 2.18% | $160.96M |
| Micron Technology, Inc. | 2.06% | $152.65M |
| Mastercard, Inc. - A | 2.04% | $151.20M |
| Cencora, Inc. | 2.00% | $148.04M |
| J.p. Morgan Chase & Co. | 1.86% | $137.75M |
| Waters Corp. | 1.79% | $132.35M |
| Ameren Corporation | 1.69% | $125.12M |
| Ppl Corp. | 1.64% | $121.38M |
| Danaher Corp. | 1.59% | $117.90M |
| Visa, Inc.-Class A Shares | 1.56% | $115.38M |
| Cytokinetics, Inc. | 1.34% | $98.90M |
| Revvity, Inc. | 1.29% | $95.14M |
| Starbucks Corp. | 1.28% | $94.40M |
| Ascendis Pharma A/s | 1.26% | $93.38M |
| Ptc, Inc. | 1.23% | $91.22M |
| Ingersoll-Rand, Inc. | 1.21% | $89.78M |
| Canadian Natural Resources | 1.21% | $89.29M |
| Apogee Therapeutics, Inc. | 1.17% | $86.73M |
| Becton Dickinson And Co. | 1.15% | $84.85M |
| Arthur J Gallagher & Co. | 1.14% | $84.13M |
| Yum Brands, Inc. | 1.12% | $83.16M |
| Doordash, Inc. - A | 1.10% | $81.50M |
| Unitedhealth Group, Inc. | 1.08% | $79.78M |
| Alnylam Pharmaceuticals, Inc. | 1.01% | $74.77M |
| Kla Corp. | 0.99% | $73.53M |
| Alphabet, Inc. Cl C | 0.99% | $72.93M |
| US Foods Holding Corp. | 0.76% | $55.90M |
| Aurora Innovation, Inc. | 0.69% | $51.30M |
| Northrop Grumman Corp. | 0.65% | $48.21M |
| Veralto Corp. | 0.64% | $47.66M |
| Lockheed Martin Corp. | 0.64% | $47.14M |
| Eli Lilly & Co. | 0.61% | $45.48M |
| Cadence Design Sys, Inc. | 0.57% | $42.23M |
| Asml Holding NV Ny | 0.56% | $41.16M |
| Arista Networks, Inc. | 0.54% | $40.17M |
| Chevron Corp. | 0.52% | $38.62M |
| Willis Towers Watson PLC | 0.52% | $38.38M |
| MSCI, Inc. | 0.52% | $38.13M |
| Vaxcyte, Inc. | 0.50% | $37.18M |
| Synopsys, Inc. | 0.46% | $33.99M |
| Philip Morris International | 0.45% | $33.64M |
| West Pharmaceutical Services | 0.45% | $33.35M |
| Wec Energy Group, Inc. | 0.45% | $33.24M |
| Bentley Systems, Inc.-Class B | 0.44% | $32.40M |
| Kkr & Co., Inc. | 0.38% | $28.43M |
| GE Aerospace | 0.38% | $28.36M |
| Spx Technologies, Inc. | 0.37% | $27.42M |
| Hca Healthcare, Inc. | 0.37% | $27.41M |
| Waste Connections, Inc. | 0.37% | $27.31M |
| Te Connectivity PLC | 0.34% | $25.14M |
| Gilead Sciences, Inc. | 0.33% | $24.62M |
| Transdigm Group, Inc. | 0.32% | $23.57M |
| Ares Management Corp. | 0.30% | $22.13M |
| Biogen, Inc. | 0.29% | $21.27M |
| Madison Square Garden Sports Corp. | 0.28% | $20.91M |
| Arxis, Inc.-A | 0.27% | $19.71M |
| Ciena Corp. | 0.27% | $19.64M |
| Conocophillips | 0.26% | $19.27M |
| Netflix, Inc. | 0.26% | $19.21M |
| Service Corp. International | 0.26% | $19.21M |
| Abbott Laboratories | 0.25% | $18.62M |
| S&P Global, Inc. | 0.25% | $18.21M |
| Cg Oncology, Inc. | 0.24% | $17.60M |
| Idex Corp. | 0.22% | $16.48M |
| Kymera Therapeutics, Inc. | 0.20% | $14.77M |
| Republic Services, Inc. | 0.20% | $14.62M |
| Marriott International -Cl A | 0.20% | $14.56M |
| Itt, Inc. | 0.18% | $13.32M |
| Hilton Worldwide Holdings, Inc. | 0.16% | $11.91M |
| Denali Therapeutics, Inc. | 0.16% | $11.49M |
| General Motors Co. | 0.14% | $10.44M |
| Erasca, Inc. | 0.14% | $10.31M |
| Entergy Corp. | 0.13% | $9.29M |
| T. Rowe Price Government Reserve Fund | 0.12% | $8.95M |
| Dyne Therapeutics, Inc. | 0.11% | $7.95M |
| Ryan Specialty Holdings | 0.08% | $6.12M |
| Moonlake Immunotherapeutics | 0.04% | $3.27M |
| Cerebras Systems, Inc. - A | 0.04% | $2.63M |
| Arcellx, Inc. Cvr | 0.00% | $0 |
TCAF overview: performance, fees, allocation and SEC filings